연구성과로 돌아가기
2023 연구성과별 연구자 정보 (36 / 2675)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| A multi-band study and exploration of the radio wave-γ-ray connection in 3C 84 | Tornikoski, M. | Tornikoski, M | 9 | Aalto Univ, Metsahovi Radio Observ, Metsahovintie 114, Kylmala 02540, Finland | gfparaschos@mpifr-bonn.mpg.de; | |||||
| A multi-band study and exploration of the radio wave-γ-ray connection in 3C 84 | Kiehlmann, S. | Kiehlmann, S | 10 | Fdn Res & Technol Hellas, Inst Astrophys, Iraklion 71110, Greece | G-7253-2019 | Kiehlmann, Sebastian | gfparaschos@mpifr-bonn.mpg.de; | |||
| A multi-band study and exploration of the radio wave-γ-ray connection in 3C 84 | Kiehlmann, S. | Kiehlmann, S | 10 | Univ Crete, Dept Phys, Iraklion 70013, Greece | G-7253-2019 | Kiehlmann, Sebastian | gfparaschos@mpifr-bonn.mpg.de; | |||
| A multi-band study and exploration of the radio wave-γ-ray connection in 3C 84 | Readhead, A. C. S. | Readhead, ACS | 11 | CALTECH, Owens Valley Radio Observ, Pasadena, CA 91125 USA | gfparaschos@mpifr-bonn.mpg.de; | |||||
| A multi-center and non-interventional registry of brentuximab vedotin in patients with relapsed or refractory CD30-positive lymphoma: the CISL1803/BRAVO study | Kim, Seok Jin | Kim, SJ | 1 | 교신저자 | Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med,Dept Internal Med, Seoul, South Korea | I-6927-2019 | KIM, JIN | kstwoh@skku.edu;drydh1685@hotmail.com; | ||
| A multi-center and non-interventional registry of brentuximab vedotin in patients with relapsed or refractory CD30-positive lymphoma: the CISL1803/BRAVO study | Kim, Seok Jin | Kim, SJ | 1 | 교신저자 | Sungkyunkwan Univ, Samsung Med Ctr, Dept Med, Div Hematol Oncol,Sch Med, 81 Irwon Ro Gangnam, Guam 06351, South Korea | I-6927-2019 | KIM, JIN | kstwoh@skku.edu;drydh1685@hotmail.com; | ||
| A multi-center and non-interventional registry of brentuximab vedotin in patients with relapsed or refractory CD30-positive lymphoma: the CISL1803/BRAVO study | Do, Young Rok | Do, YR | 2 | Dongsan Med Ctr, Daegu, South Korea | kstwoh@skku.edu;drydh1685@hotmail.com; | |||||
| A multi-center and non-interventional registry of brentuximab vedotin in patients with relapsed or refractory CD30-positive lymphoma: the CISL1803/BRAVO study | Lee, Ho-Sup | Lee, HS | 3 | Kosin Univ, Gospel Hosp, Busan, South Korea | kstwoh@skku.edu;drydh1685@hotmail.com; | |||||
| A multi-center and non-interventional registry of brentuximab vedotin in patients with relapsed or refractory CD30-positive lymphoma: the CISL1803/BRAVO study | Lee, Won-Sik | Lee, WS | 4 | Inje Univ, Busan Paik Hosp, Busan, South Korea | kstwoh@skku.edu;drydh1685@hotmail.com; | |||||
| A multi-center and non-interventional registry of brentuximab vedotin in patients with relapsed or refractory CD30-positive lymphoma: the CISL1803/BRAVO study | Kong, Jee Hyun | Kong, JH | 5 | Yonsei Univ, Wonju Severance Christian Hosp, Dept Internal Med, Div Oncol Hematol,Wonju Coll Med, Wonju, South Korea | kstwoh@skku.edu;drydh1685@hotmail.com; | |||||
| A multi-center and non-interventional registry of brentuximab vedotin in patients with relapsed or refractory CD30-positive lymphoma: the CISL1803/BRAVO study | Kong, Jee Hyun | Kong, JH | 5 | Yonsei Univ, Inst Convergence Sci, Ctr Evidence Based Med, Seoul, South Korea | kstwoh@skku.edu;drydh1685@hotmail.com; | |||||
| A multi-center and non-interventional registry of brentuximab vedotin in patients with relapsed or refractory CD30-positive lymphoma: the CISL1803/BRAVO study | Kwak, Jae-Yong | Kwak, JY | 6 | Jeonbuk Natl Univ, Med Sch, Dept Internal Med, Jeonju, Jeonbuk, South Korea | kstwoh@skku.edu;drydh1685@hotmail.com; | |||||
| A multi-center and non-interventional registry of brentuximab vedotin in patients with relapsed or refractory CD30-positive lymphoma: the CISL1803/BRAVO study | Eom, Hyeon-Seok | Eom, HS | 7 | Natl Canc Ctr, Dept Internal Med, Hematol Oncol Clin, Goyang, South Korea | kstwoh@skku.edu;drydh1685@hotmail.com; | |||||
| A multi-center and non-interventional registry of brentuximab vedotin in patients with relapsed or refractory CD30-positive lymphoma: the CISL1803/BRAVO study | Moon, Joon Ho | Moon, JH | 8 | Kyungpook Natl Univ Hosp, Daegu, South Korea | kstwoh@skku.edu;drydh1685@hotmail.com; | |||||
| A multi-center and non-interventional registry of brentuximab vedotin in patients with relapsed or refractory CD30-positive lymphoma: the CISL1803/BRAVO study | Yi, Jun Ho | Yi, JH | 9 | Chung Ang Univ Hosp, Seoul, South Korea | GXZ-8144-2022 | Yi, Jun Ho | kstwoh@skku.edu;drydh1685@hotmail.com; |
페이지 이동: